Adam Smith Conferences
Ministry of Healthcare of the Republic of Kazakhstan
Eurasian Economic Commission
AIPM KZ
SK-Pharmacy
Eurasian Pharma 2025
16th International Eurasian Pharmaceutical Forum 2025
📌Swissôtel Alatau Almaty

3–5 March 2025
Days
Hours
Minutes
Seconds
years on the market
hours of effective networking
participants
speakers
15
30
+
100
+
350
+
15 years of success
For 15 years, the Forum has been a platform for analyzing current global trends, identifying potential growth opportunities, and fostering open dialogue among regulators, business leaders, and experts.
Supported by the following organisations
Key Topics for 2025

✓ Top Executives and Government Regulators Discussion: The Future of the Industry

✓ Improving registration rules: EAEU and Uzbekistan markets

✓ Pricing regulation: Striking a fair balance

✓ Innovation and and intellectual property

✓ Commercial segment: Market status and outlook

Who are the regular attendees ?

  • Regulators and public sector representatives
  • BIG Pharma: International pharmaceutical giants.
  • Local pharmaceutical companies: From the EAEU and CIS countries.
  • Distributors: Representatives of leading distribution companies.
Extensive business networking opportunities
  • 30+ Hours of Effective Networking
  • Roundtables with Regulatory Authorities
  • One-on-One Meetings
  • Three Evening Receptions
  • And other opportunities for both formal and informal interactions on the sidelines of the forum.
VYACHESLAV LOKSHIN
President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
Dear Participants of the 16th Eurasian Pharmaceutical Forum,
It is my great pleasure to welcome you to this significant event in the world of pharmaceuticals.
The Forum serves as a unique platform for sharing experiences, discussing the latest trends and challenges in the industry, and fostering sustainable partnerships. Participation in the Forum offers not only an opportunity to gain valuable insights from leading experts but also to contribute to the development of the pharmaceutical industry in the EAEU countries.
We look forward to productive collaboration and new opportunities for the entire pharmaceutical community. I am confident that your participation will bring valuable knowledge and ideas that will drive the advancement of pharmaceutical science and industry across the Eurasian region.
LARISA MATVEEVA
Executive Director, Association of International Pharmaceutical Manufacturers
We are pleased to once again participate in the Eurasian Pharmaceutical Forum as a participant and partner in this key event for the pharmaceutical industry. Russia, Kazakhstan and all EAEU member states continue to confidently build trusting and friendly relations based on a common economic space and shared goals. Our primary mission is to serve the interests of patients by ensuring access to high quality medicines and innovative therapies.
The Association has a long history of professional cooperation in the field of EAEU regulation with colleagues from Kazakhstan, and we look forward to discussing key pharmaceutical regulatory issues at the Forum.
MUKHABBAT ASKAROVA
Director, Association of Representative Offices of Foreign Pharmaceutical Companies and Manufacturers in the Republic of Uzbekistan
The Association is an information partner of the Eurasian Pharmaceutical Forum, a leading platform for effective interaction and open dialogue among key industry stakeholders: regulators, local and international pharmaceutical companies, and organizations involved in the development, research, production, distribution, and sale of pharmaceutical products. For 15 years, we have been actively and gladly participating in the Eurasian Pharmaceutical Forum.
The participation of representatives from Uzbekistan’s pharmaceutical community in the Eurasian Pharmaceutical Forum will be a significant contribution to the development of the pharmaceutical sector in the Republic. It will also allow direct influence on shaping the future direction of the industry. Moreover, this is an exceptional opportunity for networking, experience exchange, and building new partnerships.
VADIM KUKAVA
Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
I believe this Forum is an excellent platform for discussion, where industry representatives and regulators can openly address the most pressing issues facing the pharmaceutical industry. This is particularly important given the cross-national format of the Forum, which is fully in line with current trends
Unlock business
potential with Eurasian Pharma partnership
opportunities
  • Brand Awareness
  • Exhibition Opportunities
  • Program Participation
  • Branding and Distinction
Discover the best sponsorship options with the help of our manager
By signing up, you agree to our Privacy Policy.
Partners 2025
Traditional Forum Sponsors
Media Support
Highlights from the Previous Forum
Find more photos through the link
Contacts
LLP "Adam Smith Eurasia"
Forum Director
Aruzhan Akshabayeva
+7 707 223 30 98
A.Akshabaeva@as-conf.com

For Partnership Opportunities Inquiries
Daulet Orynbasarov
+ 7 777 197 99 08
D.Orynbasarov@as-conf.com
Submit Your Question